Introduction: Intravenous immunoglobulin resistance occurs in 10% to 20% of cases of Kawasaki disease, resulting in a higher risk of coronary artery abnormalities. The objectives of the study were to determine predictive factors of intravenous immunoglobulin-resistant Kawasaki disease. Methods: We performed a retrospective Analytical study of Kawasaki disease patients treated by intravenous immunoglobulin in a northern Portugal hospital between 2006 and 2016. Patients were divided into two groups according to intravenous immunoglobulin response, resistant and non-resistant. Results: The study included 23 patients, 73.9% male gender, median age 19 months, of whom six (26.1%) were considered intravenous immunoglobulin-resistant. The groups did not differ in terms of gender or clinical manifestations. Significant differences were observed for age >4 years (66.7% vs 17.6%; p<0.04), duration of fever at the time of diagnosis and intravenous immunoglobulin administration (5 vs 9 days; p<0.01), lymphocytes at admission (1400 vs 4400 cells/μl, p=0.01), platelets at admission (255 000 vs 432 000 cells/μl, p<0.01), minimum haemoglobin (7.3 vs 9.9 g/dl, p<1) and minimum serum albumin (2.4 vs 3.4 g/dl, p=0.01). Echocardiographic abnormalities occurred in 34.8%